Dr. Paul Melton Dodd III, MD

Dr. Dodd practices at AdventHealth Daytona Beach in Daytona Beach, Florida, part of AdventHealth.

Dr. Dodd's NPI, 1538165113, was assigned on June 28, 2005. Dr. Dodd graduated from Baylor College Of Medicine in 1992. Dr. Dodd holds Florida license ME78210.

Dr. Dodd's primary practice is AdventHealth Daytona Beach, at 301 Memorial Medical Parkway, Daytona Beach, FL 32117 in Volusia County. The practice phone is (386) 231-6000.

Dr. Dodd's primary practice is AdventHealth Daytona Beach in Daytona Beach, Florida, part of AdventHealth. Dr. Dodd is also affiliated with AdventHealth Palm Coast. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Dodd to 3 more hospitals, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dodd practices, 8 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Dodd's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Dodd is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Dodd's licenses on file in 2 states: Florida and Texas.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances and immune deficiency disease among the conditions Dr. Dodd treats.

CMS data shows 284,876 Medicare services from Dr. Dodd across 60 procedure codes in 2024, for 1,310 Medicare patients. Medicare paid $2,942,444 for them.

CMS counts 1,310 Medicare patients who saw Dr. Dodd in 2024. The largest group is 75 to 84, with 568 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dodd's median patient age at 70, with 55% women.

In 2024, Dr. Dodd wrote 4,240 Medicare Part D claims for 699 patients. 76% of them were for generic drugs. CMS names the drug for 3,813 of them, across 73 drugs with 11 or more claims each, at $8,666,442 in total drug cost. In 2023, CMS named 3,149 claims across 73 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Dodd for performance year 2024, reported as part of a group. Dr. Dodd accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 678 general payments to Dr. Dodd from 59 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,547.

Dmand AI lists 2 awards for Dr. Dodd, most recently CMS Stage 1 EHR in 2014.

Dr. Dodd graduated from Baylor College Of Medicine in 1992. Dr. Dodd is a member of ASCO.

Dr. Dodd is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.